Department of Surgery, Cork University Hospital, Cork, Ireland.
Dis Colon Rectum. 2011 Aug;54(8):982-8. doi: 10.1097/DCR.0b013e31821c4944.
The status of resected lymph nodes in colon cancer determines prognosis and further treatment. The American Joint Committee on Cancer staging system has designated extramural nodules as nonnodal disease and classified them as extensions of the T category in the sixth edition and as site-specific tumor deposits in the seventh edition. Extracapsular lymph node extension is an established poor prognostic indicator in many cancers. Its significance in colon cancer has not been extensively investigated.
This study aimed to determine the prognostic significance of extramural nodules and extracapsular lymph node extension in colon cancer.
A pathological review of 114 stage III and 80 stage II colon cancers was undertaken to analyze for p-T stage, p-N stage (using the fifth, sixth, and seventh editions), and the size and contour of nodal and extramural deposits. Multivariate Cox regression models were used to determine the prognostic significance of clinicopathological parameters on survival estimates.
According to the sixth and seventh editions of the guidelines, extramural deposits were present in 29% and 31% of patients with stage III colon cancer and in 5% of patients with stage II colon cancer. Extracapsular lymph node invasion was present in 68% of cases. Multivariate analysis demonstrated that lymph node ratio, extracapsular lymph node extension, and adjuvant chemotherapy were independent prognostic factors affecting 5-year disease-free survival. The same 3 variables, in addition to extramural deposits, were independent prognostic factors affecting overall survival. The presence of extramural deposits was associated with an 11% 5-year survival, and extracapsular lymph node invasion was associated with a 33% 5-year survival.
Instead of extramural nodules being included as part of the T category or as site-specific tumor deposits, they should perhaps be classified in the metastasis category. This has major prognostic implications and may broaden the application of a number of adjuvant agents.
结肠癌切除淋巴结的状态决定了预后和进一步的治疗。美国癌症联合委员会(AJCC)分期系统将腔外结节定义为非结节性疾病,并将其归类为第六版 T 分期的延伸,以及第七版的特定部位肿瘤沉积物。包膜外淋巴结侵犯是许多癌症中已确定的不良预后指标。其在结肠癌中的意义尚未得到广泛研究。
本研究旨在确定结肠癌中腔外结节和包膜外淋巴结侵犯的预后意义。
对 114 例 III 期和 80 例 II 期结肠癌进行病理复查,分析 p-T 分期、p-N 分期(使用第五、六、七版),以及淋巴结和腔外沉积物的大小和形态。采用多变量 Cox 回归模型确定临床病理参数对生存估计的预后意义。
根据第六和第七版指南,III 期结肠癌患者中 29%和 31%存在腔外沉积物,而 II 期结肠癌患者中仅 5%存在腔外沉积物。68%的病例存在包膜外淋巴结侵犯。多变量分析表明,淋巴结比率、包膜外淋巴结侵犯和辅助化疗是影响 5 年无病生存率的独立预后因素。同样的 3 个变量,除了腔外沉积物,也是影响总生存率的独立预后因素。存在腔外沉积物的患者 5 年生存率为 11%,而存在包膜外淋巴结侵犯的患者 5 年生存率为 33%。
腔外结节不应被归类为 T 分期的一部分或特定部位的肿瘤沉积物,而应归类为转移类别。这具有重要的预后意义,并可能扩大许多辅助药物的应用范围。